Cefepime: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='10/1040142/Cv/1'> | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='10/1040142/Cv/1'> | ||
Cefepime is a fourth-generation [[cephalosporin]] antibiotic. Cefepime has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both types of organism than third-generation agents | Cefepime is a fourth-generation [[cephalosporin]] antibiotic. Cefepime has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both types of organism than third-generation agents. <ref name="a1">PMID:17448937</ref> [https://en.wikipedia.org/wiki/Cefepime Cefepime]. | ||
<scene name='10/1040142/Cv/2'>Penicillin-Binding Protein 2X (PBP2X) from Streptococcus pneumoniae in complex with Cefepime</scene> ([[5oj0]]). | <scene name='10/1040142/Cv/2'>Penicillin-Binding Protein 2X (PBP2X) from Streptococcus pneumoniae in complex with Cefepime</scene> ([[5oj0]]). | ||
Revision as of 16:25, 2 April 2024
Cefepime is a fourth-generation cephalosporin antibiotic. Cefepime has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both types of organism than third-generation agents. [1] Cefepime. (5oj0). |
| ||||||||||
ReferencesReferences
- ↑ Yahav D, Paul M, Fraser A, Sarid N, Leibovici L. Efficacy and safety of cefepime: a systematic review and meta-analysis. Lancet Infect Dis. 2007 May;7(5):338-48. PMID:17448937 doi:10.1016/S1473-3099(07)70109-3